SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-036016
Filing Date
2022-12-20
Accepted
2022-12-20 16:45:32
Documents
16
Period of Report
2022-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 66220
2 ex4-2.htm EX-4.2 192055
3 ex5.htm EX-5 13764
4 ex5_001.jpg GRAPHIC 2137
  Complete submission text file 0001493152-22-036016.txt   535302

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hrow-20221214.xsd EX-101.SCH 3747
6 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT hrow-20221214_def.xml EX-101.DEF 27283
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hrow-20221214_lab.xml EX-101.LAB 37534
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hrow-20221214_pre.xml EX-101.PRE 25902
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5543
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 221475376
SIC: 2834 Pharmaceutical Preparations